Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +4.6% | -46.6% | 1 / 3 | +32.0% | -0.34 pp | -0.50 pp | +3.5% | 1.63 | 16.27 | 80,7 | +32,0% | 1,5 | +4,6% | 16.27 | 12.80 | +27,1% |
| Pts | 0 | 0 | 4 | 12 | 4 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 6.100 (close price on 2026-10-06)EPS (TTM): 374,9
Financial charts
1.Revenue & growth
VND bn80,7Q2/26
1.Revenue & growth
VND bn80,7Q2/26
2.Profit & growth
VND bn1,41Q2/26
3.Profit mix (Penman)
VND bn7,76Q2/26
4.Margins & cost structure
%15.2%Q2/26
5.Returns & cash cycle
% · days2.9%Q2/26
6.Earnings quality & cash
VND bn-19,7Q2/26
7.Asset structure
VND bn393Q2/26
8.Funding & debt health
VND bn · times393Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %17,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %121Q2/26
Adjusted EPS growth, latest quarter
-6.7%
Average adjusted EPS growth, 3 quarters
-50.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
3.0%
Source: vnstockData through Q2/26